Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12733)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2021 (publication date) through Oct 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol 2021; 27(23): 3182-3207 [PMID: 34163105 DOI: 10.3748/wjg.v27.i23.3182] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol 2021; 27(23): 3182-3207 [PMID: 34163105 DOI: 10.3748/wjg.v27.i23.3182] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i23/3182.htm |
| Number | Citing Articles |
| 1 |
Prashika Singh, Tafadzwa Mlambo, Kristie Bloom, Claudio Mussolino, Patrick Arbuthnot, Abdullah Ely. RNA Therapeutics. Methods in Molecular Biology 2025; 2965: 323 doi: 10.1007/978-1-0716-4742-4_15
|
| 2 |
Patricia Gita Naully, Marselina Irasonia Tan, Husna Nugrahapraja, Aluicia Anita Artarini, Reza Aditama, Ernawati Arifin Giri-Rachman, Sheikh Arslan Sehgal. Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches. PLOS ONE 2024; 19(12): e0313269 doi: 10.1371/journal.pone.0313269
|
| 3 |
Rachel Matrenec, Claudia E. Oropeza, Eddie Dekoven, Carly Matrenec, Mark Maienschein-Cline, Cecilia S. Chau, Stefan J. Green, Klaus H. Kaestner, Alan McLachlan, Jae U. Jung. Foxa deficiency restricts hepatitis B virus biosynthesis through epigenic silencing. Journal of Virology 2024; 98(11) doi: 10.1128/jvi.01371-24
|
| 4 |
Samrita Naidu, Severine Margeridon. Chronic Hepatitis B Virus Persistence: Mechanisms and Insights. Cureus 2025; doi: 10.7759/cureus.78944
|
| 5 |
Liqiong Yang, Tao Zou, Yao Chen, Yueshui Zhao, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Zhangang Xiao, Jing Shen. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatology International 2022; 16(4): 741 doi: 10.1007/s12072-022-10351-6
|
| 6 |
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B. Annals of Hepatology 2025; 30(1): 101533 doi: 10.1016/j.aohep.2024.101533
|
| 7 |
Jihua Ren, Shengtao Cheng, Fang Ren, Huiying Gu, Daiqing Wu, Xinyan Yao, Ming Tan, Ailong Huang, Juan Chen. Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA. Genes & Diseases 2025; 12(1): 101215 doi: 10.1016/j.gendis.2024.101215
|
| 8 |
Mark A. Feitelson, Alla Arzumanyan, Ira Spector, Arvin Medhat. Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B. Biomedicines 2022; 10(9): 2210 doi: 10.3390/biomedicines10092210
|
| 9 |
Johannes Bächer, Lena Allweiss, Maura Dandri. SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential. Viruses 2024; 16(11): 1667 doi: 10.3390/v16111667
|
| 10 |
Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Andreea Bretcan, Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Robert Flisiak, Piotr Rzymski. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. Viruses 2023; 15(12): 2395 doi: 10.3390/v15122395
|
| 11 |
Ulrike M. Reiss, Johnny Mahlangu, Tsukasa Ohmori, Margareth C. Ozelo, Alok Srivastava, Lei Zhang. Haemophilia gene therapy—Update on new country initiatives. Haemophilia 2022; 28(S4): 61 doi: 10.1111/hae.14512
|
| 12 |
Gavin J. Marcoe, Clairine I. S. Larsen, Monnette F. Summers, Kinjal Majumder, Guangxiang George Luo. Association of hepatitis B virus genomes with active chromatin hubs challenges host replication fidelity, leading to DNA damage. Journal of Virology 2025; doi: 10.1128/jvi.01014-25
|
| 13 |
Patricia Gita Naully, Marselina Irasonia Tan, Korri Elvanita El Khobar, Caecilia H C Sukowati, Ernawati Arifin Giri-Rachman. Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics. World Journal of Hepatology 2025; 17(7): 107620 doi: 10.4254/wjh.v17.i7.107620
Abstract(300) |
Core Tip(273) |
Full Article(HTML)(936)
|
Full Article with Cover (PDF)-1555K(41)
|
Audio-7304K(9)
|
Peer-Review Report-234K(27)
|
Answering Reviewers-125K(27)
|
Supplementary Material-369K(27)
|
Full Article (PDF)-1331K(48)
|
Full Article (XML)-265K(26)
|
Times Cited (0)
|
Total Visits (2564)
|
Open
|
| 14 |
S. Yao, K. Prates, A. Freydenzon, G. Assante, A. F. McRae, M. J. Morris, N. A. Youngson. Liver‐specific deletion of de novo DNA methyltransferases protects against glucose intolerance in high‐fat diet‐fed male mice. The FASEB Journal 2024; 38(10) doi: 10.1096/fj.202301546RR
|
| 15 |
Dylan Kairuz, Prashika Singh, Tiffany Smith, Patrick Arbuthnot, Abdullah Ely, Kristie Bloom. Messenger RNA Therapeutics. RNA Technologies 2022; 13: 157 doi: 10.1007/978-3-031-08415-7_8
|
| 16 |
Mohube B. Maepa, Abdullah Ely, Anna Kramvis, Kristie Bloom, Kubendran Naidoo, Omphile E. Simani, Tongai G. Maponga, Patrick Arbuthnot. Hepatitis B Virus Research in South Africa. Viruses 2022; 14(9): 1939 doi: 10.3390/v14091939
|